Show simple item record

dc.contributor.authorClamp, Andrew R
dc.contributor.authorJayson, Gordon C
dc.date.accessioned2015-01-22T15:29:35Z
dc.date.available2015-01-22T15:29:35Z
dc.date.issued2014-12-03
dc.identifier.citationPARP inhibitors in BRCA mutation-associated ovarian cancer. 2014: Lancet Oncolen
dc.identifier.issn1474-5488
dc.identifier.pmid25481790
dc.identifier.doi10.1016/S1470-2045(14)71172-6
dc.identifier.urihttp://hdl.handle.net/10541/338688
dc.languageENG
dc.language.isoenen
dc.rightsArchived with thanks to The Lancet. Oncologyen
dc.titlePARP inhibitors in BRCA mutation-associated ovarian cancer.en
dc.typeArticleen
dc.contributor.departmentInstitute of Cancer Sciences, The Christie and University of Manchester, Withington, Manchester M20 4BX, UKen
dc.identifier.journalThe Lancet Oncologyen


Files in this item

This item appears in the following Collection(s)

Show simple item record